Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LUMIRADX LIMITED

(LMDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Advance Pre-Bell Wednesday

10/20/2021 | 09:14am EST


ę MT Newswires 2021
All news about LUMIRADX LIMITED
12/01LumiraDx's COVID-19 Test Receives US FDA Emergency Use Authorization Reissue, Now Inclu..
MT
12/01FDA Reissues LumiraDx Fast Lab Solutions' EUA for SARS CoV-2 RNA STAR Complete Molecula..
PR
12/01FDA Reissues LumiraDx Fast Lab Solutions' EUA for SARS CoV-2 RNA STAR Complete Molecula..
CI
11/15Evercore ISI Starts LumiraDx at Outperform With $20 Price Target
MT
11/10LumiraDx Q3 Loss Narrows as Revenue Jumps
MT
11/10LumiraDx Limited Reports Earnings Results for the Third Quarter and Nine Months Ended S..
CI
11/10Earnings Flash (LMDX) LUMIRADX Reports Q3 Loss $-0.16, vs. Street Est of $-0.19
MT
11/10Earnings Flash (LMDX) LUMIRADX Posts Q3 Revenue $109.1M, vs. Street Est of $100.7M
MT
11/10LumiraDx Reports Third Quarter 2021 Financial Results
PR
11/02LumiraDx to Announce Third Quarter 2021 Financial Results and Host Quarterly Conference..
PR
More news
Analyst Recommendations on LUMIRADX LIMITED
More recommendations
Financials (USD)
Sales 2021 377 M - -
Net income 2021 -52,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 71,1x
Yield 2021 -
Capitalization 2 335 M 2 335 M -
Capi. / Sales 2021 6,20x
Capi. / Sales 2022 7,35x
Nbr of Employees 1 500
Free-Float 79,5%
Chart LUMIRADX LIMITED
Duration : Period :
LumiraDx Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 9,24 $
Average target price 14,94 $
Spread / Average Target 61,7%
EPS Revisions
Managers and Directors
Ronald Zwanziger Chairman & Chief Executive Officer
Dorian LeBlanc Chief Financial Officer & VP-Global Operations
David Scott Director & Chief Technology Officer
Jerry McAleer Director & Chief Scientist
Donald M. Berwick Independent Director
Sector and Competitors
1st jan.Capi. (M$)
LUMIRADX LIMITED0.00%2 300
THERMO FISHER SCIENTIFIC34.98%247 742
DANAHER CORPORATION41.06%223 913
INTUITIVE SURGICAL, INC.24.86%121 636
SIEMENS HEALTHINEERS AG51.88%84 006
EDWARDS LIFESCIENCES CORPORATION22.72%72 123